IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 84 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $569,000 | -22.7% | 371,759 | 0.0% | 0.04% | -32.3% |
| Q1 2016 | $736,000 | -35.9% | 371,759 | 0.0% | 0.06% | -44.0% |
| Q4 2015 | $1,149,000 | -7.7% | 371,759 | 0.0% | 0.12% | -7.9% |
| Q3 2015 | $1,245,000 | -9.7% | 371,759 | 0.0% | 0.13% | +5.0% |
| Q2 2015 | $1,379,000 | 0.0% | 371,759 | 0.0% | 0.12% | -8.4% |
| Q1 2015 | $1,379,000 | -15.9% | 371,759 | 0.0% | 0.13% | -21.6% |
| Q4 2014 | $1,639,000 | +92.6% | 371,759 | 0.0% | 0.17% | +92.0% |
| Q3 2014 | $851,000 | -21.1% | 371,759 | 0.0% | 0.09% | -16.3% |
| Q2 2014 | $1,078,000 | -28.9% | 371,759 | 0.0% | 0.10% | -23.0% |
| Q1 2014 | $1,517,000 | +81.5% | 371,759 | 0.0% | 0.14% | +75.3% |
| Q4 2013 | $836,000 | +29.2% | 371,759 | 0.0% | 0.08% | +42.6% |
| Q3 2013 | $647,000 | +165.2% | 371,759 | 0.0% | 0.05% | +145.5% |
| Q2 2013 | $244,000 | – | 371,759 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
| Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
| Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
| Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
| Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
| FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
| GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
| Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
| Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |